Masitinib: What we’ve been waiting for?

We’ve all become used to hearing about new possibilities for reversing, curing, or even just halting MS progression, but most of the time we are left disappointed by research results or the experience of those who try out the “breakthrough” therapy. But the BTK inhibitor Masitinib just might live up to the hype. Sources: Lindsey Shapiro, PhD, “FDA OKs Phase 3 Trial of Masitinib for Progressive Forms of MS: Primary progressive or non-active secondary progressive MS patients eligible,” January 3, 2023 3 Studies found for: Masitinib | Multiple Sclerosis Sclerosis&draw=2&rank=1#rowId0 2 Studies found for: Masitinib | COVID-19 Dr. Brandon Beaber, “Answering MS Questions #2 (Nystagmus, Stem Cells, BBB, Urination, Walking, Exciting Research),” Oct 6, 2021 Dr. Brandon Beaber, “Masitinib for Multiple Sclerosis-Phase IIB/III trial results,” Jan 27, 2021 Gavin Giovannoni, “The Future of Multiple Sclerosis Therapy,” Premiered Jan 16, 2023 Image Sources: Hopeful emoji Hooray clipart